Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

APO-NORTRIPTYLINE CAPSULE 10 mg

Approval Number

SIN09255P

Drug Name

APO-NORTRIPTYLINE CAPSULE 10 mg

Product Name

APO-NORTRIPTYLINE CAPSULE 10 mg

Approval Date

March 18, 1997

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

N06AA10

ATC Item Name

nortriptyline

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Active Ingredients

Ingredient Name

NORTRIPTYLINE HCl

Strength

10 mg

Drug MonographNortriptyline

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy